Hengrui Medicine (01276.HK) appoints Zhu Guoxin as Senior Vice President of the company.

Zhifeng Financial News App, Hengrui Medicine (01276.HK) issued an announcement. The company's board of directors discussed and approved the "Proposal for the Nomination and Appointment of the Senior Vice President of the Company". In accordance with the company's operational needs, Mr. Zhu Guoxin is now nominated as the senior vice president of the company, with a term from the date of approval by the board of directors to the end of the current term of the board of directors.